HomeCompareFAATX vs JNJ

FAATX vs JNJ: Dividend Comparison 2026

FAATX yields 6.89% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FAATX wins by $11.5K in total portfolio value
10 years
FAATX
FAATX
● Live price
6.89%
Share price
$12.14
Annual div
$0.84
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.6K
Annual income
$1,068.43
Full FAATX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FAATX vs JNJ

📍 FAATX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFAATXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FAATX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FAATX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FAATX
Annual income on $10K today (after 15% tax)
$586.04/yr
After 10yr DRIP, annual income (after tax)
$908.17/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, FAATX beats the other by $204.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FAATX + JNJ for your $10,000?

FAATX: 50%JNJ: 50%
100% JNJ50/50100% FAATX
Portfolio after 10yr
$25.8K
Annual income
$948.10/yr
Blended yield
3.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FAATX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FAATX buys
0
JNJ buys
0
No recent congressional trades found for FAATX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFAATXJNJ
Forward yield6.89%3.36%
Annual dividend / share$0.84$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$31.6K$20.0K
Annual income after 10y$1,068.43$827.78
Total dividends collected$8.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FAATX vs JNJ ($10,000, DRIP)

YearFAATX PortfolioFAATX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,389$689.46$10,676$355.77+$713.00FAATX
2$12,921$733.88$11,407$389.39+$1.5KFAATX
3$14,603$778.08$12,198$426.53+$2.4KFAATX
4$16,447$821.87$13,056$467.62+$3.4KFAATX
5$18,464$865.09$13,987$513.12+$4.5KFAATX
6$20,664$907.62$14,998$563.56+$5.7KFAATX
7$23,059$949.32$16,098$619.52+$7.0KFAATX
8$25,664$990.08$17,295$681.69+$8.4KFAATX
9$28,490$1,029.81$18,599$750.82+$9.9KFAATX
10$31,553$1,068.43$20,022$827.78+$11.5KFAATX

FAATX vs JNJ: Complete Analysis 2026

FAATXStock

The investment seeks growth, income and conservation of capital. The fund normally invests a greater portion of its assets in fixed income, equity-income and balanced funds as it continues past its target date. The advisor attempts to achieve its investment objectives by investing in a mix of American Funds in different combinations and weightings. The underlying American Funds represent a variety of fund categories, including growth-and-income funds, equity-income funds, balanced funds and fixed income funds. The fund categories represent differing investment objectives.

Full FAATX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FAATX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FAATX vs SCHDFAATX vs JEPIFAATX vs OFAATX vs KOFAATX vs MAINFAATX vs ABBVFAATX vs MRKFAATX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.